Combined immunotherapy and antiangiogenic therapy of cancer with microencapsulated cells

Human Gene Therapy

Volumn 15, Issue 10, 2004, Pages 945-959

  Cirone, Pasquale ^a   Bourgeois, Jacqueline M ^a   Shen, Feng ^a   Chang, Patricia L ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOSTATIN; HYBRID PROTEIN; RECOMBINANT INTERLEUKIN 2; VON WILLEBRAND FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CELL TRANSPLANTATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DNA MODIFICATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; FEMALE; MELANOMA; MICROENCAPSULATION; MITOSIS INDEX; MOUSE; MYOBLAST; NONHUMAN; RECOMBINANT DNA TECHNOLOGY; T LYMPHOCYTE ACTIVATION; TISSUE DISTRIBUTION;

ANGIOGENESIS INHIBITORS; ANGIOSTATINS; ANIMALS; APOPTOSIS; CELL LINE; CELL SURVIVAL; CYTOKINES; DRUG COMPOUNDING; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE THERAPY; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NECROSIS; NEOPLASMS; RECOMBINANT PROTEINS; SPLEEN; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; TIME FACTORS; TRANSGENES; VON WILLEBRAND FACTOR;

ANIMALIA;

EID: 5644278734     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2004.15.945     Document Type: Article

References (32)

1. ADDISON, C.L., BRACIAK, T., RALSTON, R., MULLER, W.J., GAULDIE, J., and GRAHAM, F.L. (1995). Intratumoral injection of an adenovirus expressing interleukin 2 induces regression and immunity in a murine breast cancer model. Proc. Natl. Acad. Sci. U.S.A. 92, 8522-8526.
2. AL HENDY, A., HORTELANO, G., TANNENBAUM, G.S., and CHANG, P.L. (1995). Correction of the growth defect in dwarf mice with nonautologous microencapsulated myoblasts: An alternate approach to somatic gene therapy. Hum. Gene Ther. 6, 165-175.
3. BENELLI, R., MORINI, M., CARROZZINO, F., FERRARI, N., MINGHELLI, S., SANTI, L., CASSATELLA, M., NOONAN, D.M., and ALBINI, A. (2002). Neutrophils as a key cellular target for angiostatin: Implications for regulation of angiogenesis and inflammation. FASEB J. 16, 267-269.
4. CAO, X., LI, Q., JU, D.W., WANG, Q., TAO, Q., and WANG, J. (1999a). Enhanced antitumor effects of bone marrow transplantation in combination with fibroblast-mediated IL-2 and IL-3 gene therapy. Transplantation 67, 1242-1250.
5. CAO, X., WANG, Q., JU, D.W., TAO, Q., and WANG, J. (1999b). Efficient induction of local and systemic antitumor immune response by liposome-mediated intratumoral co-transfer of interleukin-2 gene and interleukin-6 gene. J. Exp. Clin. Cancer Res. 18, 191-200.
6. CAO, Y., JI, R.W., DAVIDSON, D., SCHALLER, J., MARTI, D., SOHNDEL, S., McCANCE, S.G., O'REILLY, M.S., LLINAS, M., and FOLKMAN, J. (1996). Kringle domains of human angiostatin: Characterization of the anti-proliferative activity on endothelial cells. J. Biol. Chem. 271, 29461-29467.
7. CAO, Y., O'REILLY, M.S., MARSHALL, B., FLYNN, E., JI, R.W., and FOLKMAN, J. (1998). Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases. J. Clin. Invest. 101, 1055-1063.
8. CHANG, P.L., SHEN, N., and WESTCOTT, A.J. (1993). Delivery of recombinant gene products with microencapsulated cells in vivo. Hum. Gene Ther. 4, 433-440.
9. CHANG, P.L., VAN RAAMSDONK, J.M., HORTELANO, G., BARSOUM, S.C., MACDONALD, N.C., and STOCKLEY, T.L. (1999). The in vivo delivery of heterologous proteins by microencapsulated recombinant cells. Trends Biotechnol. 17, 78-83.
10. CIRONE, P., SALLER, R.M., and CHANG, P.L. (2001). Immuno-isolation in oncology: A mini-review. Curr. Pharm. Biotechnol. 2, 269-277.
11. CIRONE, P., BOURGEOIS, J.M., AUSTIN, R.C., and CHANG, P.L. (2002). A novel approach to tumor suppression with microencapsulated recombinant cells. Hum. Gene Ther. 13, 1157-1166.
12. CIRONE, P., BOURGEOIS, J.M., and CHANG, P.L. (2003). Antiangiogenic cancer therapy with microencapsulated cells. Hum. Gene Ther. 14, 1065-1077.
13. CLAESSON-WELSH, L., WELSH, M., ITO, N., ANAND-APTE, B., SOKER, S., ZETTER, B., O'REILLY, M., and FOLKMAN, J. (1998). Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD. Proc. Natl. Acad. Sci. U.S.A. 95, 5579-5583.
14. GILLIS, S., FERM, M.M., OU, W., and SMITH, K.A. (1978). T cell growth factor: Parameters of production and a quantitative microassay for activity. J. Immunol. 120, 2027-2032.
15. GRISCELLI, F., LI, H., BENNACEUR-GRISCELLI, A., SORIA, J., OPOLON, P., SORIA, C., PERRICAUDET, M., YEH, P., and LU, H. (1998). Angiostatin gene transfer: Inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest. Proc. Natl. Acad. Sci. U.S.A. 95, 6367-6372.
16. HATTON, M.W., DAY, S., SOUTHWARD, S.M., DERESKE, M., ROSS, B., SEIDLITZ, E., SINGH, G., and RICHARDSON, M. (2001). Metabolism of rabbit angiostatin glycoforms I and II in rabbits: Angiostatin-I leaves the intravascular space faster and appears to have greater anti-angiogenic activity than angiostatin-II. J. Lab. Clin. Med. 138, 83-93.
17. HE, P., TANG, Z.Y., YE, S.L., LIU, B.B., and LIU, Y.K. (2000). The targeted expression of interleukin-2 in human hepatocellular carcinoma cells. J. Exp. Clin. Cancer Res. 19, 183-187.
18. HEIKE, Y., TAKAHASHI, M., OHIRA, T., NARUSE, I., HAMA, S., OHE, Y., KASAI, T., FUKUMOTO, H., OLSEN, K.J., PODACK, E.E., and SAIJO, N. (1997). Genetic immunotherapy by intrapleural, intraperitoneal and subcutaneous injection of IL-2 gene-modified Lewis lung carcinoma cells. Int. J. Cancer 73, 844-849.
19. JOKI, T., MACHLUF, M., ATALA, A., ZHU, J., SEYFRIED, N.T., DUNN, I.F., ABE, T., CARROLL, R.S., and BLACK, P.M. (2001). Continuous release of endostatin from microencapsulated engineered cells for tumor therapy. Nat. Biotechnol. 19, 35-39.
20. LI, J., GYORFFY, S., LEE, S., and KWOK, C.S. (1996). Effect of recombinant human interleukin 2 on neutrophil adherence to endothelial cells in vitro. Inflammation 20, 361-372.
21. LI, J., GYORFFY, S., RINKES, I.H., KWOK, C.S., and AUSTIN, R.C. (1999). Preparation and characterization of a recombinant humanized single-chain Fv antibody/human interleukin-2 fusion protein directed against the HER-2/neu (c-erbB2) proto-oncogene product, p185. Tumor Targeting 4, 105-114.
22. MACDONALD, N.J., MURAD, A.C., FOGLER, W.E., LU, Y., and SIM, B.K. (1999). The tumor-suppressing activity of angiostatin protein resides within kringles 1 to 3. Biochem. Biophys. Res. Commun. 264, 469-477.
23. MANIOTIS, A.J., FOLBERG, R., HESS, A., SEFTOR, E.A., GARDNER, L.M., PE'ER, J., TRENT, J.M., MELTZER, P.S., and HENDRIX, M.J. (1999). Vascular channel formation by human melanoma cells in vivo and in vitro: Vasculogenic mimicry. Am. J. Pathol. 155, 739-752.
24. NIETHAMMER, A.G., XIANG, R., BECKER, J.C., WODRICH, H., PERTL, U., KARSTEN, G., ELICEIRI, B.P., and REISFELD, R.A. (2002). A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth. Nat. Med. 8, 1369-1375.
25. O'REILLY, M.S., HOLMGREN, L., SHING, Y., CHEN, C., ROSENTHAL, R.A., MOSES, M., LANE, W.S., CAO, Y., SAGE, E.H., and FOLKMAN, J. (1994). Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315-328.
26. O'REILLY, M.S., HOLMGREN, L., CHEN, C., and FOLKMAN, J. (1996). Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat. Med. 2, 689-692.
27. READ, T.A., STENSVAAG, V., VINDENES, H., ULVESTAD, E., BJERKVIG, R., and THORSEN, F. (1999). Cells encapsulated in alginate: A potential system for delivery of recombinant proteins to malignant brain tumours. Int. J. Dev. Neurosci. 17, 653-663.
28. ROSS, CJ., BASTEDO, L., MAIER, S.A., SANDS, M.S., and CHANG, P.L. (2000a). Treatment of a lysosomal storage disease, mucopolysaccharidosis VII, with microencapsulated recombinant cells. Hum. Gene Ther. 11, 2117-2127.
29. ROSS, C.J., RALPH, M., and CHANG, P.L. (2000b). Somatic gene therapy for a neurodegenerative disease using microencapsulated recombinant cells. Exp. Neurol. 166, 276-286.
30. TOLOZA, E.M., HUNT, K., SWISHER, S., MCBRIDE, W., LAU, R., PANG, S., RHOADES, K., DRAKE, T., BELLDEGRUN, A., GLASPY, J., and ECONOMOU, J.S. (1996). In vivo cancer gene therapy with a recombinant interleukin-2 adenovirus vector. Cancer Gene Ther. 3, 11-17.
31. VAN RAAMSDONK, J.M., and CHANG, P.L. (2001). Osmotic pressure test: A simple, quantitative method to assess the mechanical stability of alginate microcapsules. J. Biomed. Mater. Res. 54, 264-271.
32. VAN RAAMSDONK, J.M., ROSS, C.J., POTTER, M.A., KURACHI, S., KURACHI, K., STAFFORD, D.W., and CHANG, P.L. (2002). Treatment of hemophilia B in mice with nonautologous somatic gene therapeutics. J. Lab. Clin. Med. 139, 35-42.